France· FR:62490835
GELUCYSTINE 500 mg, gélule
A medicinal product containing l-cystine, registered in France by JOLLY JATEL.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- L-CYSTINE
- Manufacturer
- JOLLY JATEL
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 2
- cip1334009321403292 plaquette(s) thermoformée(s) PVC-aluminium de 10 gélule(s)
- cip1334009323121466 plaquette(s) thermoformée(s) PVC-aluminium de 10 gélule(s)
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
L-cystine in 2 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainCRECIL 500 mg CAPSULAS DURASLaboratorios Vinas S.A.
- United KingdomCystine 500mg capsulesSpecial Order
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Spain · Cistina, Crecil
- Italy · Cistidil
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c5c128df-7ae9-439c-a535-5631418f7f0e GET /v1/drugs/c5c128df-7ae9-439c-a535-5631418f7f0e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "62490835",
"date_amm": "1995-10-30",
"type_amm": "Procédure nationale",
"numero_ue": null,
"substance": "L-CYSTINE",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "gélule",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about l-cystine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.